Cytosorbents (CTSO) Return on Capital Employed Growth (5y) (2016 - 2026)
Cytosorbents (CTSO) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,977.00 |
| Mar 31, 2026 | -3,974.00 |
| Dec 31, 2025 | -2,991.00 |
| Sep 30, 2025 | -1,527.00 |
| Jun 30, 2025 | 1,440.00 |
| Mar 31, 2025 | 3,067.00 |
| Dec 31, 2024 | 6,129.00 |
| Sep 30, 2024 | 4,614.00 |
| Jun 30, 2024 | 951.00 |
| Mar 31, 2024 | -1,023.00 |
| Dec 31, 2023 | -2,907.00 |
| Sep 30, 2023 | -2,794.00 |
| Jun 30, 2023 | -1,925.00 |
| Mar 31, 2023 | -1,088.00 |
| Dec 31, 2022 | 484.00 |
| Sep 30, 2022 | 345.00 |
| Jun 30, 2022 | 7,170.00 |
| Mar 31, 2022 | 35,162.00 |
| Dec 31, 2021 | 16,267.00 |
| Sep 30, 2021 | 11,616.00 |